In in vitro models of AD, it was illustrated that overexpression of APP or Aβ treatment causes profound fragmentation of mitochondria with elevated Drp1 levels and altered distribution of mitochondria, which likely trigger Aβ-induced synaptic defects in neuronal cultures [49,94]. Here, APP is linked to Alzheimer disease.